Balyasny Asset Management L.P.
Position in CATX — Perspective Therapeutics, Inc.
CIK 1218710
Chicago, IL
Position in CATX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,321,963
-$1,164,935 QoQ
Shares Held
3,320,224
+10.9% QoQ
Ownership
2.91%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 130 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names. CATX ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,163 | $344,218,967 | |
| 2 | MDT |
Medtronic plc
|
986,367 | $77,163,489 | |
| 3 | GKOS |
GLAUKOS Corp
|
491,636 | $68,711,047 | |
| 4 | ABT |
Abbott Laboratories
|
740,808 | $67,220,917 | |
| 5 | EW |
Edwards Lifesciences Corp
|
456,202 | $41,268,032 | |
| 6 | 739,829 | $18,406,945 | |||
| 7 | BBNX |
Beta Bionics, Inc.
|
855,682 | $13,408,536 | |
| 8 | AXGN |
Axogen, Inc.
|
253,498 | $11,709,072 |
All Filings in CATX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,321,963 | 3,320,224 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,486,898 | 2,994,460 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $417,615 | 130,914 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $132,950 | 111,723 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||